Literature DB >> 4073000

Low plasma cholecystokinin response after ingestion of a test meal in patients with chronic pancreatitis.

A Funakoshi, I Nakano, H Shinozaki, H Ibayashi, K Tateishi, T Hamaoka.   

Abstract

Postprandial responses of plasma cholecystokinin (CCK) in patients with severe chronic pancreatitis (n = 7) were studied. Plasma CCK level rose from 11.2 +/- 1.8 pg/ml at the basal level to a maximum of 23.3 +/- 3.0 pg/ml at 10 min after the ingestion of a liquid meal in healthy subjects (n = 6). However, such significant plasma CCK response to the meal was not observed in patients with chronic pancreatitis in whom CCK levels rose from a basal level of 9.7 +/- 0.91 pg/ml to a peak of 13.8 +/- 1.6 pg/ml at 60 min. It is suggested that the low response of CCK after the meal might reflect impaired function of the enteropancreatic axis to intraluminal stimuli in patients with severe chronic pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4073000

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  12 in total

1.  Effect of loxiglumide (CR-1505) on bombesin- and meal-stimulated plasma cholecystokinin in man.

Authors:  J B Jansen; M C Jebbink; B R Douglas; C B Lamers
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 2.  Perspectives of CCK antagonists in pancreatic research and clinical use. Part I.

Authors:  L C Rovati
Journal:  Int J Pancreatol       Date:  1991-04

3.  Effect of methionine-enkephalin analog (FK 33-824) on plasma motilin.

Authors:  K Sekiya; A Funakoshi; I Nakano; H Nawata; K Kato; H Ibayashi
Journal:  Gastroenterol Jpn       Date:  1986-08

4.  Plasma CCK levels in patients with pancreatic insufficiency.

Authors:  T Bozkurt; G Adler; I Koop; H Koop; W Türmer; R Arnold
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

5.  Effect of oral protease inhibitor administration on gallbladder motility in patients with mild chronic pancreatitis.

Authors:  M Sugiyama; Y Atomi; N Wada; A Kuroda; T Muto
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

6.  No negative feedback regulation between plasma CCK levels and luminal tryptic activities in patients with pancreatic insufficiency.

Authors:  T Nakamura; K Takebe; K Kudoh; M Ishii; K Imamura; H Kikuchi; F Kasai; Y Tandoh; N Yamada; Y Arai
Journal:  Int J Pancreatol       Date:  1995-02

7.  Diagnostic role of gastrointestinal hormones in patients with chronic pancreatitis.

Authors:  W H Nealon; R D Beauchamp; C M Townsend; G Boyd; M Shabot; J C Thompson
Journal:  Ann Surg       Date:  1986-10       Impact factor: 12.969

8.  Changes in plasma and duodenal cholecystokinin concentrations after pancreatic duct occlusion in rats.

Authors:  K Miyasaka; A Funakoshi; A Jimi; R Nakamura; M Matsumoto; K Kitani
Journal:  Dig Dis Sci       Date:  1992-03       Impact factor: 3.199

9.  Diurnal profile of pancreatic exocrine secretion and plasma levels of gut hormones (cholecystokinin and pancreatic polypeptide).

Authors:  I Nakano; A Funakoshi; H Shinozaki; K Miyazaki; K Tateishi; T Hamaoka
Journal:  Gastroenterol Jpn       Date:  1987-12

10.  Reversible gall bladder dysfunction in severe pancreatic insufficiency.

Authors:  A A Masclee; J B Jansen; F H Corstens; C B Lamers
Journal:  Gut       Date:  1989-06       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.